You are here
Products
CD3 [PC3/188A]
Product group: | Primary |
Monoclonal/ Polyclonal: | Monoclonal |
Clone: | PC3/188A |
Host: | Mouse |
Isotype: | IgG1 |
Application: | Flow cytometry (FC), Immunofluorescence (IF), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blot (WB) |
Application notes: | 50-200 |
Conjugation Type: | Unconjugated |
Lightchain type: | Kappa |
Reactivity: | Human, Mouse, Rat |
General notes: | Localization: membrane, cytoplasm. |
Buffer: | citrate PH6.0 or EDTA pH8.0 |
UNSPSC code: | 12352203 |
CD3 is a protein complex and T cell co-receptor that is involved in activating both the cytotoxic T cell and T helper cells. It is composed of four distinct chains CD3γ, CD3δ, and two CD3ε chains in mammals. These chains associate with the T-cell receptor (TCR) and the CD3-zeta (ζ-chain) to generate activation signal in T lymphocytes. The TCR, CD3-zeta, and the other CD3 molecules together constitute the TCR complex. CD3 is initially expressed in the cytoplasm of pro-thymocytes, the stem cells from which T-cells arise in the thymus. The pro-thymocytes differentiate into common thymocytes, and then into medullary thymocytes, and it is at this latter stage that CD3 antigen begins to migrate to the cell membrane. The antigen is highly specific marker for T cells, remains present in almost all T-cell lymphomas and leukaemias, and can therefore be used to distinguish them from superficially similar B-cell and myeloid neoplasms. This monoclonal antibody recognizes the epsilon-chain of CD3. C
CD3 [PC3/188A]
CD3 (Cluster of Differentiation 3) is a complex of proteins that associates directly with the T cell antigen receptor (TCR). CD3 is composed of five invariant polypeptide chains that associate to form three dimers. The five invariant chains of CD3 are labeled gamma, delta, epsilon, zeta, and eta. The CD3 is involved in T cell development and survival. It is expressed on T cells in Thymus, peripheral lymphoid tissue, blood and bone marrow. CD3 is a commonly used marker for identification of T cell and T cell derived malignancies. This CD3 antibody has been validated by the 9th International Conference on Human Leukocyte Differentiation Antigens (HLDA9).
Alternative names: